 | • レポートコード：QYR2104Z1074 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん検診/スクリーニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（磁気共鳴画像法（MRI）、ヒトパピローマウイルス（HPV）検査、結腸内視鏡検査、その他）、用途別市場規模（肺がん、血液がん、骨がん、胆嚢がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん検診/スクリーニングの市場動向 ・企業の競争状況、市場シェア ・がん検診/スクリーニングの種類別市場規模（磁気共鳴画像法（MRI）、ヒトパピローマウイルス（HPV）検査、結腸内視鏡検査、その他） ・がん検診/スクリーニングの用途別市場規模（肺がん、血液がん、骨がん、胆嚢がん、その他） ・がん検診/スクリーニングの北米市場規模2016-2027（アメリカ、カナダ） ・がん検診/スクリーニングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん検診/スクリーニングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん検診/スクリーニングの中南米市場規模2016-2027（メキシコ、ブラジル） ・がん検診/スクリーニングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dias Orin、Epigenetics、Techlab、Positive Bioscience、Genextropy、M Genomics、20/20 GeneSystems、AB SCIEX、Abbott Laboratories） ・結論 |
Screening means checking your body for cancer before you have symptoms.
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
Market Analysis and Insights: Global Cancer Testing/Screening Market
The global Cancer Testing/Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Testing/Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Testing/Screening market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Testing/Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Testing/Screening market.
Global Cancer Testing/Screening Scope and Market Size
Cancer Testing/Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Testing/Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Magnetic Resonance Imaging (MRI)
Human Papillomavirus (HPV) Testing
Colonoscopy
Others
Segment by Application
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Testing/Screening Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Magnetic Resonance Imaging (MRI)
1.2.3 Human Papillomavirus (HPV) Testing
1.2.4 Colonoscopy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Testing/Screening Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lung Cancer
1.3.3 Blood Cancer
1.3.4 Bone Cancer
1.3.5 Gall Bladder Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Testing/Screening Market Perspective (2016-2027)
2.2 Cancer Testing/Screening Growth Trends by Regions
2.2.1 Cancer Testing/Screening Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Testing/Screening Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Testing/Screening Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Testing/Screening Industry Dynamic
2.3.1 Cancer Testing/Screening Market Trends
2.3.2 Cancer Testing/Screening Market Drivers
2.3.3 Cancer Testing/Screening Market Challenges
2.3.4 Cancer Testing/Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Testing/Screening Players by Revenue
3.1.1 Global Top Cancer Testing/Screening Players by Revenue (2016-2021)
3.1.2 Global Cancer Testing/Screening Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Testing/Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Testing/Screening Revenue
3.4 Global Cancer Testing/Screening Market Concentration Ratio
3.4.1 Global Cancer Testing/Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Testing/Screening Revenue in 2020
3.5 Cancer Testing/Screening Key Players Head office and Area Served
3.6 Key Players Cancer Testing/Screening Product Solution and Service
3.7 Date of Enter into Cancer Testing/Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Testing/Screening Breakdown Data by Type
4.1 Global Cancer Testing/Screening Historic Market Size by Type (2016-2021)
4.2 Global Cancer Testing/Screening Forecasted Market Size by Type (2022-2027)
5 Cancer Testing/Screening Breakdown Data by Application
5.1 Global Cancer Testing/Screening Historic Market Size by Application (2016-2021)
5.2 Global Cancer Testing/Screening Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Testing/Screening Market Size (2016-2027)
6.2 North America Cancer Testing/Screening Market Size by Type
6.2.1 North America Cancer Testing/Screening Market Size by Type (2016-2021)
6.2.2 North America Cancer Testing/Screening Market Size by Type (2022-2027)
6.2.3 North America Cancer Testing/Screening Market Size by Type (2016-2027)
6.3 North America Cancer Testing/Screening Market Size by Application
6.3.1 North America Cancer Testing/Screening Market Size by Application (2016-2021)
6.3.2 North America Cancer Testing/Screening Market Size by Application (2022-2027)
6.3.3 North America Cancer Testing/Screening Market Size by Application (2016-2027)
6.4 North America Cancer Testing/Screening Market Size by Country
6.4.1 North America Cancer Testing/Screening Market Size by Country (2016-2021)
6.4.2 North America Cancer Testing/Screening Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Testing/Screening Market Size (2016-2027)
7.2 Europe Cancer Testing/Screening Market Size by Type
7.2.1 Europe Cancer Testing/Screening Market Size by Type (2016-2021)
7.2.2 Europe Cancer Testing/Screening Market Size by Type (2022-2027)
7.2.3 Europe Cancer Testing/Screening Market Size by Type (2016-2027)
7.3 Europe Cancer Testing/Screening Market Size by Application
7.3.1 Europe Cancer Testing/Screening Market Size by Application (2016-2021)
7.3.2 Europe Cancer Testing/Screening Market Size by Application (2022-2027)
7.3.3 Europe Cancer Testing/Screening Market Size by Application (2016-2027)
7.4 Europe Cancer Testing/Screening Market Size by Country
7.4.1 Europe Cancer Testing/Screening Market Size by Country (2016-2021)
7.4.2 Europe Cancer Testing/Screening Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Testing/Screening Market Size (2016-2027)
8.2 Asia-Pacific Cancer Testing/Screening Market Size by Type
8.2.1 Asia-Pacific Cancer Testing/Screening Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Testing/Screening Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Testing/Screening Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Testing/Screening Market Size by Application
8.3.1 Asia-Pacific Cancer Testing/Screening Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Testing/Screening Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Testing/Screening Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Testing/Screening Market Size by Region
8.4.1 Asia-Pacific Cancer Testing/Screening Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Testing/Screening Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Testing/Screening Market Size (2016-2027)
9.2 Latin America Cancer Testing/Screening Market Size by Type
9.2.1 Latin America Cancer Testing/Screening Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Testing/Screening Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Testing/Screening Market Size by Type (2016-2027)
9.3 Latin America Cancer Testing/Screening Market Size by Application
9.3.1 Latin America Cancer Testing/Screening Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Testing/Screening Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Testing/Screening Market Size by Application (2016-2027)
9.4 Latin America Cancer Testing/Screening Market Size by Country
9.4.1 Latin America Cancer Testing/Screening Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Testing/Screening Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Testing/Screening Market Size (2016-2027)
10.2 Middle East & Africa Cancer Testing/Screening Market Size by Type
10.2.1 Middle East & Africa Cancer Testing/Screening Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Testing/Screening Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Testing/Screening Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Testing/Screening Market Size by Application
10.3.1 Middle East & Africa Cancer Testing/Screening Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Testing/Screening Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Testing/Screening Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Testing/Screening Market Size by Country
10.4.1 Middle East & Africa Cancer Testing/Screening Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Testing/Screening Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Dias Orin
11.1.1 Dias Orin Company Details
11.1.2 Dias Orin Business Overview
11.1.3 Dias Orin Cancer Testing/Screening Introduction
11.1.4 Dias Orin Revenue in Cancer Testing/Screening Business (2016-2021)
11.1.5 Dias Orin Recent Development
11.2 Epigenetics
11.2.1 Epigenetics Company Details
11.2.2 Epigenetics Business Overview
11.2.3 Epigenetics Cancer Testing/Screening Introduction
11.2.4 Epigenetics Revenue in Cancer Testing/Screening Business (2016-2021)
11.2.5 Epigenetics Recent Development
11.3 Techlab
11.3.1 Techlab Company Details
11.3.2 Techlab Business Overview
11.3.3 Techlab Cancer Testing/Screening Introduction
11.3.4 Techlab Revenue in Cancer Testing/Screening Business (2016-2021)
11.3.5 Techlab Recent Development
11.4 Positive Bioscience
11.4.1 Positive Bioscience Company Details
11.4.2 Positive Bioscience Business Overview
11.4.3 Positive Bioscience Cancer Testing/Screening Introduction
11.4.4 Positive Bioscience Revenue in Cancer Testing/Screening Business (2016-2021)
11.4.5 Positive Bioscience Recent Development
11.5 Genextropy
11.5.1 Genextropy Company Details
11.5.2 Genextropy Business Overview
11.5.3 Genextropy Cancer Testing/Screening Introduction
11.5.4 Genextropy Revenue in Cancer Testing/Screening Business (2016-2021)
11.5.5 Genextropy Recent Development
11.6 M Genomics
11.6.1 M Genomics Company Details
11.6.2 M Genomics Business Overview
11.6.3 M Genomics Cancer Testing/Screening Introduction
11.6.4 M Genomics Revenue in Cancer Testing/Screening Business (2016-2021)
11.6.5 M Genomics Recent Development
11.7 20/20 GeneSystems
11.7.1 20/20 GeneSystems Company Details
11.7.2 20/20 GeneSystems Business Overview
11.7.3 20/20 GeneSystems Cancer Testing/Screening Introduction
11.7.4 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2016-2021)
11.7.5 20/20 GeneSystems Recent Development
11.8 AB SCIEX
11.8.1 AB SCIEX Company Details
11.8.2 AB SCIEX Business Overview
11.8.3 AB SCIEX Cancer Testing/Screening Introduction
11.8.4 AB SCIEX Revenue in Cancer Testing/Screening Business (2016-2021)
11.8.5 AB SCIEX Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Cancer Testing/Screening Introduction
11.9.4 Abbott Laboratories Revenue in Cancer Testing/Screening Business (2016-2021)
11.9.5 Abbott Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Testing/Screening Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Magnetic Resonance Imaging (MRI)
Table 3. Key Players of Human Papillomavirus (HPV) Testing
Table 4. Key Players of Colonoscopy
Table 5. Key Players of Others
Table 6. Global Cancer Testing/Screening Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Testing/Screening Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Testing/Screening Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Testing/Screening Market Share by Regions (2016-2021)
Table 10. Global Cancer Testing/Screening Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Testing/Screening Market Share by Regions (2022-2027)
Table 12. Cancer Testing/Screening Market Trends
Table 13. Cancer Testing/Screening Market Drivers
Table 14. Cancer Testing/Screening Market Challenges
Table 15. Cancer Testing/Screening Market Restraints
Table 16. Global Cancer Testing/Screening Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Testing/Screening Market Share by Players (2016-2021)
Table 18. Global Top Cancer Testing/Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Testing/Screening as of 2020)
Table 19. Ranking of Global Top Cancer Testing/Screening Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Testing/Screening Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Testing/Screening Product Solution and Service
Table 23. Date of Enter into Cancer Testing/Screening Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Testing/Screening Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Testing/Screening Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Testing/Screening Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Testing/Screening Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Testing/Screening Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Testing/Screening Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Testing/Screening Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Testing/Screening Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Testing/Screening Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Testing/Screening Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Testing/Screening Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Testing/Screening Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Testing/Screening Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Testing/Screening Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Testing/Screening Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Testing/Screening Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Testing/Screening Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Testing/Screening Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Testing/Screening Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Testing/Screening Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Testing/Screening Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Testing/Screening Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Testing/Screening Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Testing/Screening Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Testing/Screening Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Testing/Screening Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Testing/Screening Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Testing/Screening Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Testing/Screening Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Testing/Screening Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Testing/Screening Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Testing/Screening Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Testing/Screening Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Testing/Screening Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Testing/Screening Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Testing/Screening Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Testing/Screening Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Testing/Screening Market Size by Country (2022-2027) & (US$ Million)
Table 63. Dias Orin Company Details
Table 64. Dias Orin Business Overview
Table 65. Dias Orin Cancer Testing/Screening Product
Table 66. Dias Orin Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 67. Dias Orin Recent Development
Table 68. Epigenetics Company Details
Table 69. Epigenetics Business Overview
Table 70. Epigenetics Cancer Testing/Screening Product
Table 71. Epigenetics Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 72. Epigenetics Recent Development
Table 73. Techlab Company Details
Table 74. Techlab Business Overview
Table 75. Techlab Cancer Testing/Screening Product
Table 76. Techlab Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 77. Techlab Recent Development
Table 78. Positive Bioscience Company Details
Table 79. Positive Bioscience Business Overview
Table 80. Positive Bioscience Cancer Testing/Screening Product
Table 81. Positive Bioscience Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 82. Positive Bioscience Recent Development
Table 83. Genextropy Company Details
Table 84. Genextropy Business Overview
Table 85. Genextropy Cancer Testing/Screening Product
Table 86. Genextropy Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 87. Genextropy Recent Development
Table 88. M Genomics Company Details
Table 89. M Genomics Business Overview
Table 90. M Genomics Cancer Testing/Screening Product
Table 91. M Genomics Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 92. M Genomics Recent Development
Table 93. 20/20 GeneSystems Company Details
Table 94. 20/20 GeneSystems Business Overview
Table 95. 20/20 GeneSystems Cancer Testing/Screening Product
Table 96. 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 97. 20/20 GeneSystems Recent Development
Table 98. AB SCIEX Company Details
Table 99. AB SCIEX Business Overview
Table 100. AB SCIEX Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 101. AB SCIEX Recent Development
Table 102. Abbott Laboratories Company Details
Table 103. Abbott Laboratories Business Overview
Table 104. Abbott Laboratories Cancer Testing/Screening Product
Table 105. Abbott Laboratories Revenue in Cancer Testing/Screening Business (2016-2021) & (US$ Million)
Table 106. Abbott Laboratories Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Testing/Screening Market Share by Type: 2020 VS 2027
Figure 2. Magnetic Resonance Imaging (MRI) Features
Figure 3. Human Papillomavirus (HPV) Testing Features
Figure 4. Colonoscopy Features
Figure 5. Others Features
Figure 6. Global Cancer Testing/Screening Market Share by Application: 2020 VS 2027
Figure 7. Lung Cancer Case Studies
Figure 8. Blood Cancer Case Studies
Figure 9. Bone Cancer Case Studies
Figure 10. Gall Bladder Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Cancer Testing/Screening Report Years Considered
Figure 13. Global Cancer Testing/Screening Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Cancer Testing/Screening Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Cancer Testing/Screening Market Share by Regions: 2020 VS 2027
Figure 16. Global Cancer Testing/Screening Market Share by Regions (2022-2027)
Figure 17. Global Cancer Testing/Screening Market Share by Players in 2020
Figure 18. Global Top Cancer Testing/Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Testing/Screening as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Cancer Testing/Screening Revenue in 2020
Figure 20. Global Cancer Testing/Screening Revenue Market Share by Type (2016-2021)
Figure 21. Global Cancer Testing/Screening Revenue Market Share by Type (2022-2027)
Figure 22. North America Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Cancer Testing/Screening Market Share by Type (2016-2027)
Figure 24. North America Cancer Testing/Screening Market Share by Application (2016-2027)
Figure 25. North America Cancer Testing/Screening Market Share by Country (2016-2027)
Figure 26. United States Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cancer Testing/Screening Market Share by Type (2016-2027)
Figure 30. Europe Cancer Testing/Screening Market Share by Application (2016-2027)
Figure 31. Europe Cancer Testing/Screening Market Share by Country (2016-2027)
Figure 32. Germany Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cancer Testing/Screening Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Cancer Testing/Screening Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Cancer Testing/Screening Market Share by Region (2016-2027)
Figure 42. China Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cancer Testing/Screening Market Share by Type (2016-2027)
Figure 50. Latin America Cancer Testing/Screening Market Share by Application (2016-2027)
Figure 51. Latin America Cancer Testing/Screening Market Share by Country (2016-2027)
Figure 52. Mexico Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cancer Testing/Screening Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Cancer Testing/Screening Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Cancer Testing/Screening Market Share by Country (2016-2027)
Figure 58. Turkey Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Cancer Testing/Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Dias Orin Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 62. Epigenetics Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 63. Techlab Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 64. Positive Bioscience Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 65. Genextropy Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 66. M Genomics Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 67. 20/20 GeneSystems Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 68. AB SCIEX Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 69. Abbott Laboratories Revenue Growth Rate in Cancer Testing/Screening Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のDNA腸がんスクリーニングキット市場規模・現状・予測（2021年-2027年） It is a non-invasive genetic test for bowel cancer which examines the DNA code for 11 genes known to cause an increased risk of bowel cancer. It is performed on a blood sample and if possible it is more informative to test a relative who has had bowel cancer first. Market Analysis and Insights: Glob…- 世界の甲状腺がん検査市場規模・現状・予測（2021年-2027年） Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technologic…
- 世界の子宮頸がんスクリーニング市場規模・現状・予測（2021年-2027年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 世界の前立腺がん検査市場規模・現状・予測（2021年-2027年） Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ult…
- 世界の乳がんスクリーニング検査市場規模・現状・予測（2021年-2027年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…